Brainstorm Cell Therapeutics Inc. (BCLI) Net income 2016–2025
Brainstorm Cell Therapeutics Inc. (BCLI) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$10.3MFY2025 · since FY2016: -$5.0M → -$10.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.3M | +11.3% |
| FY2024 | -$11.6M | +32.4% |
| FY2023 | -$17.2M | +29.2% |
| FY2022 | -$24.3M | +0.7% |
| FY2021 | -$24.5M | +23.1% |
| FY2020 | -$31.8M | -36.8% |
| FY2019 | -$23.3M | -66.7% |
| FY2018 | -$13.9M | -181.7% |
| FY2017 | -$5.0M | +0.6% |
| FY2016 | -$5.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice